These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1656032)

  • 1. Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism.
    Kintzer PP; Peterson ME
    J Vet Intern Med; 1991; 5(3):182-90. PubMed ID: 1656032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms.
    Kintzer PP; Peterson ME
    J Am Vet Med Assoc; 1994 Jul; 205(1):54-61. PubMed ID: 7928549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS; Farver TB
    J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Angles JM; Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane.
    Peterson ME; Kintzer PP
    Vet Clin North Am Small Anim Pract; 1997 Mar; 27(2):255-72. PubMed ID: 9076906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. o,p'-DDD (mitotane) treatment of canine pituitary-dependent hyperadrenocorticism.
    Peterson ME
    J Am Vet Med Assoc; 1983 Mar; 182(5):527-8. PubMed ID: 6300010
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of ACTH stimulation tests to monitor the treatment of canine hyperadrenocorticism.
    Dunn KJ; Herrtage ME; Dunn JK
    Vet Rec; 1995 Aug; 137(7):161-5. PubMed ID: 8553523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternative protocol for the medical management of canine pituitary-dependent hyperadrenocorticism.
    Rijnberk A; Belshaw BE
    Vet Rec; 1988 May; 122(20):486-8. PubMed ID: 3420770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW; Feldman EC; Shinsako J
    Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism.
    Aldridge C; Behrend EN; Kemppainen RJ; Lee-Fowler TM; Martin LG; Ward CR; Bruyette D; Pannu J; Gaillard P; Lee HP
    J Vet Intern Med; 2016 Sep; 30(5):1637-1641. PubMed ID: 27425787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic availability of o,p'-DDD in normal dogs, fasted and fed, and in dogs with hyperadrenocorticism.
    Watson AD; Rijnberk A; Moolenaar AJ
    Res Vet Sci; 1987 Sep; 43(2):160-5. PubMed ID: 3685628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
    Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
    J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane.
    Reine NJ
    Clin Tech Small Anim Pract; 2007 Feb; 22(1):18-25. PubMed ID: 17542193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
    Guptill L; Scott-Moncrieff JC; Bottoms G; Glickman L; Johnson M; Glickman N; Nelson R; Bertoy E
    J Am Vet Med Assoc; 1997 Apr; 210(8):1158-61. PubMed ID: 9108922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of cortisol and cortisone in healthy dogs and dogs with pituitary-dependent hyperadrenocorticism treated with trilostane.
    Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
    Vet Rec; 2008 Oct; 163(16):477-81. PubMed ID: 18931355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the role of aldosterone in hypertension associated with spontaneous pituitary-dependent hyperadrenocorticism in dogs.
    Goy-Thollot I; Péchereau D; Kéroack S; Dezempte JC; Bonnet JM
    J Small Anim Pract; 2002 Nov; 43(11):489-92. PubMed ID: 12463264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of non-selective adrenocorticolysis by o,p'-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism.
    den Hertog E; Braakman JC; Teske E; Kooistra HS; Rijnberk A
    Vet Rec; 1999 Jan; 144(1):12-7. PubMed ID: 10028568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cortisol response to ketoconazole administration in dogs with hyperadrenocorticism.
    Feldman EC; Bruyette DS; Nelson RW; Farver TB
    J Am Vet Med Assoc; 1990 Jul; 197(1):71-8. PubMed ID: 2370223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perianal adenomas and hypertestosteronemia in a spayed bitch with pituitary-dependent hyperadrenocorticism.
    Dow SW; Olson PN; Rosychuk RA; Withrow SJ
    J Am Vet Med Assoc; 1988 May; 192(10):1439-41. PubMed ID: 2839445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.